Baseline characteristics

Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer · Source last updated 2021-10-19

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      647

   2. group Id

      BG001

      value

      665

   3. group Id

      BG002

      value

      1312

   units

   Participants

groups

1. description

   Patients receive doxorubicin hydrochloride IV over approximately 15-30 minutes on day 1, cisplatin IV over 60-90 minutes on day 1, paclitaxel IV over 3 hours on day 2, and filgrastim SC on days 3-12 or pegfilgrastim SC on day 3. Treatment repeats every 21 days for 7 courses in the absence of disease progression or unacceptable toxicity.

   id

   BG000

   title

   Arm I (Doxorubicin Hydrochloride, Cisplatin, Paclitaxel)

2. description

   Patients receive paclitaxel IV over 3 hours and carboplatin IV over 30-60 minutes on day 1. Treatment repeats every 21 days for 7 courses in the absence of disease progression or unacceptable toxicity.

   id

   BG001

   title

   Arm II (Paclitaxel, Carboplatin)

3. description

   Total of all reporting groups

   id

   BG002

   title

   Total

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            19

         2. group Id

            BG001

            value

            18

         3. group Id

            BG002

            value

            37

         title

         <40 years

      2. measurements

         1. group Id

            BG000

            value

            67

         2. group Id

            BG001

            value

            70

         3. group Id

            BG002

            value

            137

         title

         40 -49 years

      3. measurements

         1. group Id

            BG000

            value

            192

         2. group Id

            BG001

            value

            219

         3. group Id

            BG002

            value

            411

         title

         50-59 years

      4. measurements

         1. group Id

            BG000

            value

            256

         2. group Id

            BG001

            value

            244

         3. group Id

            BG002

            value

            500

         title

         60-60 years

      5. measurements

         1. group Id

            BG000

            value

            113

         2. group Id

            BG001

            value

            114

         3. group Id

            BG002

            value

            227

         title

         >=70 years

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Age, Customized

   unit Of Measure

   Participants

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            647

         2. group Id

            BG001

            value

            665

         3. group Id

            BG002

            value

            1312

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            0

         2. group Id

            BG001

            value

            0

         3. group Id

            BG002

            value

            0

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

population Description

Eligible and treated patients

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice